Human Alkaline Phosphatase (ALPL) activation kit by CRISPRa
CAT#: GA100173
ALPL CRISPRa kit - CRISPR gene activation of human alkaline phosphatase, biomineralization associated
CNY 12255.00
Specifications
Product Data | |
Format | 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug) |
Symbol | ALPL |
Locus ID | 249 |
Kit Components | GA100173G1, Alkaline Phosphatase gRNA vector 1 in pCas-Guide-GFP-CRISPRa GA100173G2, Alkaline Phosphatase gRNA vector 2 in pCas-Guide-GFP-CRISPRa GA100173G3, Alkaline Phosphatase gRNA vector 3 in pCas-Guide-GFP-CRISPRa 1 CRISPRa-Enhancer vector, SKU GE100056 1 CRISPRa scramble vector, SKU GE100077 |
Reference Data | |
RefSeq | NM_000478, NM_001127501, NM_001177520, NM_001369805, NM_001369803, NM_001369804 |
Synonyms | AP-TNAP; APTNAP; HOPS; TNAP; TNSALP |
Summary | This gene encodes a member of the alkaline phosphatase family of proteins. There are at least four distinct but related alkaline phosphatases: intestinal, placental, placental-like, and liver/bone/kidney (tissue non-specific). The first three are located together on chromosome 2, while the tissue non-specific form is located on chromosome 1. The product of this gene is a membrane bound glycosylated enzyme that is not expressed in any particular tissue and is, therefore, referred to as the tissue-nonspecific form of the enzyme. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate the mature enzyme. This enzyme may play a role in bone mineralization. Mutations in this gene have been linked to hypophosphatasia, a disorder that is characterized by hypercalcemia and skeletal defects. [provided by RefSeq, Oct 2015] |
Documents
Resources
基因表达相关资源 |
Other Versions
SKU | Description | Size | Price |
---|---|---|---|
KN405692 | ALPL - KN2.0, Human gene knockout kit via CRISPR, non-homology mediated. |
CNY 8680.00 |